Search results
8 lut 2023 · FY 2021 PRCRP Overarching Challenges: Develop strategies and biomarkers to predict cancer risk, treatment resistance, recurrence, and advanced disease to mitigate risk in target populations. Improve prevention strategies, diagnosis, treatment, and outcomes for patients in underserved or under recognized populations.
31 maj 2022 · The purpose of this review is to present a systematic, comprehensive, and critical analysis of the cancer-preventive potential of C. papaya extracts, fractions, and isolated phytochemicals with a special emphasis on the cellular and molecular mechanisms of action.
21 mar 2024 · applications based on their scientific peer-reviewed ratings, the funding landscape, portfolio composition, programmatic intent, and relevance to congressional language. During October-November 2022, CDMRP convened 39 FY 2022 PRCRP peer review panels.
This review summarizes the results of extract-based or specific compound-based investigations and emphasizes the aspects that warrant future research to explore the bioactives in C. papaya for their anticancer activities.
Results: Different constituents of Carica papaya responsible for anticancer activities have been discussed. Papaya extract for the treatment of breast, liver, blood, pancreas, skin, prostate, and colon cancer have also been reported.
16 paź 2024 · Since Fiscal Year 2009, the Peer Reviewed Cancer Research Program (PRCRP) has been charged by U.S. Congress to fund innovative basic, applied, and translational cancer research to support Service members, their families, and the American public.
31 maj 2022 · The purpose of this review is to present a systematic, comprehensive, and critical analysis of the cancer-preventive potential of C. papaya extracts, fractions, and isolated phytochemicals...
